Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global H1N1 Vaccines market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market is expected to play significant role in the development of demand and improvement due to COVID-19..
Based on the type of product, the global H1N1 Vaccines market segmented into
Inactivated vaccines
Type II
Based on the end-use, the global H1N1 Vaccines market classified into
Swine flu
Application 2
Based on geography, the global H1N1 Vaccines market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Medimmune
AstraZeneca
Novartis
GlaxoSmithKline
Serum Institute
Sinovac Biotech
Zydus Cadila
BioCSL
Mitsubishi Tanabe Pharma
Protein Sciences Corporation
Baxter International
Sanofi Pastuer
Commonwealth Serum Laboratories (CSL)
End of Summary
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL H1N1 VACCINES INDUSTRY
2.1 Summary about H1N1 Vaccines Industry
2.2 H1N1 Vaccines Market Trends
2.2.1 H1N1 Vaccines Production & Consumption Trends
2.2.2 H1N1 Vaccines Demand Structure Trends
2.3 H1N1 Vaccines Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Inactivated vaccines
4.2.2 Type II
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Swine flu
4.3.2 Application 2
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Inactivated vaccines
5.2.2 Type II
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Swine flu
5.3.2 Application 2
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Inactivated vaccines
6.2.2 Type II
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Swine flu
6.3.2 Application 2
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Inactivated vaccines
7.2.2 Type II
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Swine flu
7.3.2 Application 2
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Inactivated vaccines
8.2.2 Type II
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Swine flu
8.3.2 Application 2
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Inactivated vaccines
9.2.2 Type II
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Swine flu
9.3.2 Application 2
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Medimmune
10.1.2 AstraZeneca
10.1.3 Novartis
10.1.4 GlaxoSmithKline
10.1.5 Serum Institute
10.1.6 Sinovac Biotech
10.1.7 Zydus Cadila
10.1.8 BioCSL
10.1.9 Mitsubishi Tanabe Pharma
10.1.10 Protein Sciences Corporation
10.1.11 Baxter International
10.1.12 Sanofi Pastuer
10.1.13 Commonwealth Serum Laboratories (CSL)
10.2 H1N1 Vaccines Sales Date of Major Players (2017-2020e)
10.2.1 Medimmune
10.2.2 AstraZeneca
10.2.3 Novartis
10.2.4 GlaxoSmithKline
10.2.5 Serum Institute
10.2.6 Sinovac Biotech
10.2.7 Zydus Cadila
10.2.8 BioCSL
10.2.9 Mitsubishi Tanabe Pharma
10.2.10 Protein Sciences Corporation
10.2.11 Baxter International
10.2.12 Sanofi Pastuer
10.2.13 Commonwealth Serum Laboratories (CSL)
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Tables and Figures
List of Table
1.Table H1N1 Vaccines Product Type Overview
2.Table H1N1 Vaccines Product Type Market Share List
3.Table H1N1 Vaccines Product Type of Major Players
4.Table Brief Introduction of Medimmune
5.Table Brief Introduction of AstraZeneca
6.Table Brief Introduction of Novartis
7.Table Brief Introduction of GlaxoSmithKline
8.Table Brief Introduction of Serum Institute
9.Table Brief Introduction of Sinovac Biotech
10.Table Brief Introduction of Zydus Cadila
11.Table Brief Introduction of BioCSL
12.Table Brief Introduction of Mitsubishi Tanabe Pharma
13.Table Brief Introduction of Protein Sciences Corporation
14.Table Brief Introduction of Baxter International
15.Table Brief Introduction of Sanofi Pastuer
16.Table Brief Introduction of Commonwealth Serum Laboratories (CSL)
17.Table Products & Services of Medimmune
18.Table Products & Services of AstraZeneca
19.Table Products & Services of Novartis
20.Table Products & Services of GlaxoSmithKline
21.Table Products & Services of Serum Institute
22.Table Products & Services of Sinovac Biotech
23.Table Products & Services of Zydus Cadila
24.Table Products & Services of BioCSL
25.Table Products & Services of Mitsubishi Tanabe Pharma
26.Table Products & Services of Protein Sciences Corporation
27.Table Products & Services of Baxter International
28.Table Products & Services of Sanofi Pastuer
29.Table Products & Services of Commonwealth Serum Laboratories (CSL)
30.Table Market Distribution of Major Players
31.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
32.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
33.Table Global H1N1 Vaccines Market Forecast (Million USD) by Region 2021f-2026f
34.Table Global H1N1 Vaccines Market Forecast (Million USD) Share by Region 2021f-2026f
35.Table Global H1N1 Vaccines Market Forecast (Million USD) by Demand 2021f-2026f
36.Table Global H1N1 Vaccines Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
1.Figure Global H1N1 Vaccines Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global H1N1 Vaccines Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global H1N1 Vaccines Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global H1N1 Vaccines Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global H1N1 Vaccines Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global H1N1 Vaccines Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global H1N1 Vaccines Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Inactivated vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Type II Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Swine flu Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Application 2 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Inactivated vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Type II Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Swine flu Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Application 2 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Inactivated vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Type II Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Swine flu Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Application 2 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Inactivated vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Type II Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Swine flu Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Application 2 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Inactivated vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Type II Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Swine flu Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Application 2 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Inactivated vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Type II Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Swine flu Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Application 2 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure H1N1 Vaccines Sales Revenue (Million USD) of Medimmune 2017-2020e
60.Figure H1N1 Vaccines Sales Revenue (Million USD) of AstraZeneca 2017-2020e
61.Figure H1N1 Vaccines Sales Revenue (Million USD) of Novartis 2017-2020e
62.Figure H1N1 Vaccines Sales Revenue (Million USD) of GlaxoSmithKline 2017-2020e
63.Figure H1N1 Vaccines Sales Revenue (Million USD) of Serum Institute 2017-2020e
64.Figure H1N1 Vaccines Sales Revenue (Million USD) of Sinovac Biotech 2017-2020e
65.Figure H1N1 Vaccines Sales Revenue (Million USD) of Zydus Cadila 2017-2020e
66.Figure H1N1 Vaccines Sales Revenue (Million USD) of BioCSL 2017-2020e
67.Figure H1N1 Vaccines Sales Revenue (Million USD) of Mitsubishi Tanabe Pharma 2017-2020e
68.Figure H1N1 Vaccines Sales Revenue (Million USD) of Protein Sciences Corporation 2017-2020e
69.Figure H1N1 Vaccines Sales Revenue (Million USD) of Baxter International 2017-2020e
70.Figure H1N1 Vaccines Sales Revenue (Million USD) of Sanofi Pastuer 2017-2020e
71.Figure H1N1 Vaccines Sales Revenue (Million USD) of Commonwealth Serum Laboratories (CSL) 2017-2020e
72.